Long COVID is the patient-coined term for the disease entity whereby persistent symptoms
ensue in a significant proportion of those who have had COVID-19, whether asymptomatic …

NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was
identified as a pivotal pathway in mediating inflammatory responses. However, with …

Background The aim of this study was to systematically synthesise the global evidence on
the prevalence of persistent symptoms in a general post COVID-19 population. Methods A …

First infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
associated with increased risk of acute and postacute death and sequelae in various organ …

Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has threatened global
mental health, both indirectly via disruptive societal changes and directly via …

The neurologic manifestations of acute COVID-19 are well characterized, but a
comprehensive evaluation of postacute neurologic sequelae at 1 year has not been …

Executive summary As of May 31, 2022, there were 6· 9 million reported deaths and 17· 2
million estimated deaths from COVID-19, as reported by the Institute for Health Metrics and …

COVID-19, with persistent and new onset of symptoms such as fatigue, post-exertional
malaise, and cognitive dysfunction that last for months and impact everyday functioning, is …

The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection—also referred to as Long COVID—have been described, but whether …

Background The long-term health consequences of COVID-19 remain largely unclear. The
aim of this study was to describe the long-term health consequences of patients with COVID …